Lipika Goyal

17PUBLICATIONS
180CO-AUTHORS
Haematological tumoursMolecular targetsCancer cell biologyCancer therapy (excl. chemotherapy and radiation therapy)Dance and dance studies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Jun 12, 2026
Activating a B cell immune response regresses immunologically cold tumours.

|Dec 19, 2025
Broadening the gates: Analysis of potentially modifiable study entry criteria in pancreatic and biliary tract cancer trials.

Fen Saj, Felicity K Namayanja, Lianchun Xiao

|Sep 30, 2025
Final Results from a First-in-Human Phase I Study of the Dual Isocitrate Dehydrogenase (IDH) 1/2 Inhibitor, LY3410738, in Advanced Solid Tumors Harboring IDH1 or IDH2 Mutations.

James J Harding, Do-Youn Oh, Teresa Macarulla Mercade

|Jun 14, 2024
Dual checkpoint inhibition in gallbladder cancer: Bridging new hope with the need for biomarkers.

Fen Saj, Y Linda Wu, Shubham Pant

|May 24, 2024
Publisher Correction: Pemigatinib in previously treated solid tumors with activating FGFR1-FGFR3 alterations: phase 2 FIGHT-207 basket trial.

Jordi Rodón, Silvia Damian, Muhammad Furqan

|May 21, 2024
Evaluating Debio 1347 in Patients with FGFR Fusion-Positive Advanced Solid Tumors from the FUZE Multicenter, Open-Label, Phase II Basket Trial.

Petros Grivas, Elena Garralda, Funda Meric-Bernstam

Pageof 3

Frequent Collaborators

4 joint publications

Do-Youn Oh

3 joint publications

Jordi Rodón

3 joint publications

Tomoya Yokota

3 joint publications

Jochen K Lennerz